Three Cents A Day is Not Enough - Resourcing HIV-related Harm Reduction on a Global Basis. Stimson GV, Cook C, Bridge J, et al (2010)

cover-coming-soon

People who inject drugs should benefit from the large increases in the global resources available for HIV. However, it is difficult to measure how much of global HIV spending actually goes into harm reduction. Although harm reduction is relatively invisible in national and international budgets, it is possible to calculate a plausible estimate of HIVrelated harm reduction expenditure in low and middle income countries between 2007 and 2009. These results demonstrate the degree to which the international community is failing to address the issue of HIV among injecting drug using populations.

 

 

 

Download this publication

Economic Cost of HIV and AIDS in India. Das S, Mukhopadhyay, A and Ray T (2009)

Economic Cost of HIV and AIDS in India. Das S, Mukhopadhyay, A and Ray T (2009) According to the latest available estimates, there are currently about 2.5 million people living with HIV or AIDS in India, corresponding to a HIV prevalence rate of 0.36 percent for the population ages 15–49 (IIPS 2007). While HIV prevalence thus remains relatively low, there are sev- eral factors that are unique to India’s HIV epidemic, and need to be taken into account when assessing the impact of HIV and AIDS.

Download this publication

The Global Economic Crisis and HIV Prevention and Treatment Programmes: Vulnerabilities and Impact. UNAIDS and The World Bank (2009)

The Global Economic Crisis and HIV Prevention and Treatment Programmes: Vulnerabilities and Impact. UNAIDS and The World Bank (2009) The global economic crisis threatens recent gains in health and poverty reduction in developing countries. What is the effect of the crisis on HIV programmes, especially in high HIV prevalence countries? What are the possible consequences? What can be done to avoid negative impacts? Information collected in late March 2009 from respondents in 71 countries

Download this publication

National AIDS Spending Assessment 2007-2008. National AIDS Authority Cambodia (2009)

National AIDS Spending Assessment 2007-2008. National AIDS Authority Cambodia (2009) This report includes the results of the second National AIDS Spending Assessment (NASA II) in Cambodia, covering the fiscal years 2007 and 2008. NASA II was carried out from December 2008 to January 2009 under the leadership of the National AIDS Authority (NAA). It was designed to build in a coherent manner on NASA I which was carried out at the end of 2007 and covered the year 2006.

Download this publication

Nepal: National AIDS Spending Assessment Report 2007. HIV/AIDS and STI Control Board Nepal and UNAIDS (2009)

Nepal: National AIDS Spending Assessment Report 2007. HIV/AIDS and STI Control Board Nepal and UNAIDS (2009) NASA 2007 aimed to assess overall spending on the HIV/AIDS programme by examining programme financial flows – Sources of Funds, Agents, and Providers - beneficiary population, and specific functions and programmes where spending was being made. Attempt was made to see if sufficient resources were being invested in enhancing the capacity of the organizations’
human resources to implement HIV/AIDS programme activities, as well as to enhancing overall national capacity for external and internal resource mobilisation.

Download this publication

Economic Aspect of HIV/AIDS Control and Injecting Drug Use in Indonesia. Siregar AYM, Komarudin D, Leuwol B, et al (2009)

Technical Annex for a Proposed Grant in the Amount of SDR 6.60 Million (US$lO.O Million Equivalent) to the Islamic Republic of Afghanistan for a HIV/AIDS Prevention Project. World Bank (2007)

In Indonesia, the HIV epidemic is increasing, and among the fastest growing in Asia. The epidemic is concentrated among injecting drug users (IDUs) and their sexual partners in most parts of the country, but generalised in some other parts.


Download this publication

Introduction of National AIDS Spending Assessment (NASA) to the National Advisory Committee on AIDS in Fiji. Jahnsen J. (2009)

immage

This report supports the proposed UNDP financed technical assistance intended to introduce the National AIDS Spending Assessment methodology to the National Advisory Committee (NACA). Further development, implementation and institutionalization of the NASA methodology is expected to be lead by the NACA in order to standardize the classification of HIV and AIDS expenditures among all stakeholders. It is projected that NACA’s analysis of the tracked expenditures will enable valuable information to be disclosed that will influence the strategic allocation of future resources to Fiji’s HIV/AIDS initiative. Data generated through NASA can also be used to measure the nation’s commitment and effort, which is an important component of the UNGASS Declaration, and therefore will also help Fiji to address some of the gaps that currently exist in its UNGASS reporting.

Download Publication

National HIV/AIDS Action Plan and Budget 2005-06: A Public/Private Partnership to Scale Up the HIV/AIDS Response in Nepal. Ministry of Health Nepal (2008)

National HIV/AIDS Action Plan and Budget 2005-06: A Public/Private Partnership to Scale Up the HIV/AIDS Response in Nepal. Ministry of Health Nepal (2008) The National HIV/AIDS Action Plan and Budget for 2005-2006 was produced following extensive consultation about the extent of the problem, and what needs to be done about it. Stakeholders – i.e. government officials, representatives of beneficiary groups, broader civil society actors, and donor partners – are all agreed that the Action Plan provides the single point of reference for the HIV/AIDS response in Nepal.

Download this publication

Background Report: Cost-effectiveness of Injecting Drug User Interventions to Prevent HIV in Nepal. Alban A and Manuel C (2007)

Background Report: Cost-effectiveness of Injecting Drug User Interventions to Prevent HIV in Nepal. Alban A and Manuel C (2007) This paper has two objectives. The first is to examine the robustness of two different epidemiological models; these models were used to determine the impact of IDU interventions in Nepal when interventions are scaled-up to reach 60% of IDUs, as recommended by UNAIDS. The second objective is to disseminate the outcome of two cost- effectiveness analyses of IDU interventions in Nepal. These analyses used identical data sets to determine the cost-effectiveness ratios under various scenarios of intervention coverage.

Download this publication

Technical Report: AIDS Spending in Indonesia 2006-2007 (Draft). National AIDS Commission Indonesia and UNAIDS (2007)

Technical Report: AIDS Spending in Indonesia 2006-2007 (Draft). National AIDS Commission Indonesia and UNAIDS (2007) The National AIDS Spending Assessment (NASA) is a tool/ method that had been introduced by the UNAIDS Geneva to measure the commitment of a nation in combating a global epidemic disease such as HIV and AIDS. The development of NASA 2006-2007 is a jointly teamwork involved highly motivated senior staffs of the National AIDS Commission, UNAIDS Indonesia, Department of Health and other Sectors at the central level, as well as colleagues from 3 selected provinces.

Download this publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_National_and_Subnational_HIV_Estimates_and_Projections_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_NASA_Report_2016-2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_TB_Global_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-Global-AIDS-Update_Asia-Pacific_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-changing-laws-that-discriminate_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_HIV_National_Strategic_Information_2018-22.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_National_STI_and_HIV_Strategy.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_GAP_progress_report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
Calendar of events
Mar
1
(1 Mar - 1 Mar)
Mar
3
Mar
8
(8 Mar - 8 Mar)